Stratvocate offers a wealth of information and easy-to-use tools for those involved in federal contracting.

Subject: Illumina DRAGEN GCP Lvl 4 1-year License
Solicitation Number: 75N98026Q01035
Notice Type: PRESOL
NAICS: 541714
Set-Aside: No Set aside used
Notice Published: 09-02-26
Response Due: 09-10-26

Agency: Department of Health and Human Services
Office: NATIONAL INSTITUTES OF HEALTH
Contact: Ijada Fields This email address is being protected from spambots. You need JavaScript enabled to view it.
Office Address: BETHESDA, MD 20892
Place of Performance: North Bethesda, MD


Click for official SAM (FBO) notice, additional information, and accompanying attachments

The National Institute of Neurological Disorders and Stroke (NINDS), Neurodegenerative Diseases Research Section (NDRS), requires a 12-month subscription/access to the Illumina DRAGEN GCP Level 4 platform to process approximately 1,300,000 GB of whole-genome sequencing data derived from 10,000 human genomes. The platform must support graph-based alignment to the human reference genome (hg38), accurate variant calling, and detection of single-nucleotide variants, insertions/deletions, structural variants, copy number variants, and repeat expansions. The platform must be fully compatible with Illumina-generated sequencing data and existing DRAGEN-processed datasets. The contractor shall provide access and operational availability of the DRAGEN GCP platform and processing capability sufficient to analyze the 10,000 genomes during the 12-month period of performance.